10-Q: Livento Group Reports Q2 Profit Amid Revenue Decline

Livento Group, Inc. reported a net profit for Q2 2025, though core revenues decreased and the six-month period saw a swing to a net loss.

Summary

• Livento Group, Inc. filed its Quarterly Report on Form 10-Q for the period ended June 30, 2025.
• For the three months ended June 30, 2025, the company reported total revenues of $234,131, a decrease from $558,707 in the prior year's comparable quarter.
• Other income, primarily from movie projects, significantly increased to $535,600 for the three months ended June 30, 2025, from $365,307 in the prior year's comparable quarter.
• The company achieved a net income of $147,331 for the three months ended June 30, 2025, compared to a net income of $262,792 for the same period in 2024.
• For the six months ended June 30, 2025, total revenues were $546,788, down from $865,328 in the prior year's comparable period.
• The six-month period ended June 30, 2025, resulted in a net loss of $530,209, a significant shift from a net profit of $818,364 for the same period in 2024.
• Cash and cash equivalents increased to $65,238 as of June 30, 2025, from $7,970 as of June 30, 2024.
• Net cash provided by operating activities improved significantly to $499,240 for the six months ended June 30, 2025, compared to a net cash outflow of $131,058 in the prior year.
• The company entered into a financing agreement for $75,600 on June 30, 2025, with a 10% annual interest rate and an April 15, 2026, maturity date, convertible into common shares at a 35% discount.
• Total common shares outstanding as of June 30, 2025, were 1,239,753,594.

Sentiment

Score: 3

Explanation: The company shows some positive developments in cash flow from operations and strategic shifts towards movie projects and AI software, with expected revenue growth in the latter. However, significant declines in core revenue, a swing to a substantial net loss for the six-month period, and stated inadequacy of cash for growth plans indicate ongoing financial challenges and high operational risk. The reliance on future capital raises and the speculative nature of its current business ventures contribute to a low sentiment.

Positives

• Cash at period end increased significantly to $65,238 as of June 30, 2025, from $7,970 as of June 30, 2024.
• Net cash provided by operating activities significantly improved to $499,240 for the six months ended June 30, 2025, compared to a net cash outflow of $131,058 for the same period in 2024.
• Other income, primarily from movie projects, increased to $535,600 for the three months ended June 30, 2025, from $365,307 in the prior year's comparable quarter.
• Two out of 45 movie projects successfully entered distribution, indicating progress in the BOXO Productions segment.
• The Elisee AI machine learning program is expected to increase annual revenue from approximately $1.5 million to $2.5 million starting in 2025.
• Total liabilities decreased to $3,412,242 as of June 30, 2025, from $4,181,456 as of December 31, 2024.
• Accounts payable decreased to $206,235 as of June 30, 2025, from $455,989 as of December 31, 2024.

Negatives

• Core revenues significantly decreased to $234,131 for the three months ended June 30, 2025, from $558,707 in the prior year's comparable quarter.
• Core revenues for the six months ended June 30, 2025, significantly decreased to $546,788 from $865,328 in the prior year's comparable period.
• Gross profit worsened to a loss of $356,909 for the three months ended June 30, 2025, from a loss of $68,208 in the prior year's comparable quarter.
• Gross profit worsened to a loss of $838,056 for the six months ended June 30, 2025, from a loss of $489,222 in the prior year's comparable period.
• Net income for the three months ended June 30, 2025, decreased to $147,331 from $262,792 in the prior year's comparable quarter.
• Net results for the six months ended June 30, 2025, swung to a net loss of $530,209 from a net profit of $818,364 in the prior year's comparable period.
• Accumulated deficit increased to $20,384,787 as of June 30, 2025, from $19,704,578 as of December 31, 2024.
• Total assets decreased to $45,164,634 as of June 30, 2025, from $47,591,411 as of December 31, 2024.
• Net cash used in investing activities significantly increased to an outflow of $696,597 for the six months ended June 30, 2025, from an outflow of $48,407 in the prior year's comparable period.
• Cash resources of approximately $189,577 as of June 30, 2025, are deemed inadequate to execute growth plans, as stated in the risk factors.

Risks

• Limited resources and potential inability to raise additional capital needed to fund operations and planned increased investment levels.
• Operating at a net loss of $1,180,537 for the period ended June 30, 2025, with cash resources of approximately $189,577 on June 30, 2025, which are inadequate to execute growth plans.
• Cybersecurity threats to movie projects and Elisee software, as data is stored online.
• Risk of cash flow problems if clients face financial difficulties, impacting the ability to pay liabilities.
• BOXO's movie production projects are capital intensive, frequently costing over $30 million, and rely on investor funding, with delays in raising capital potentially affecting results.
• BOXO relies on personal relationships rather than formal agreements, posing a risk that key consultants may leave.
• The software development market is highly competitive and fragmented, with no assurance that the company's unique platform will remain commercially viable or maintain a competitive advantage.
• Minority stockholders will likely not have a meaningful vote in corporate actions due to control by officers and directors through super-voting preferred stock.
• High costs associated with SEC reporting requirements and compliance with the Sarbanes-Oxley Act of 2002, which may adversely affect the ability to continue as a going concern.
• No assurance that common stock will be listed on the OTCQB or any other stock exchange, currently traded on Pink Sheets.
• Common stock is likely considered a penny stock, which may make it more difficult for investors to sell shares due to suitability requirements.
• Emerging growth company status under the JOBS Act of 2012 may make common stock less attractive to investors and make it more challenging to raise capital.
• The right to issue preferred stock with rights, preferences, and privileges that may adversely affect common stock.

Future Outlook

Management believes the AI financial management software segment will provide meaningful revenue, with the Elisee program expected to generate $2.5 million annually from 2025. The company anticipates increased income streams from Global Dot Logistics and BOXO movie projects once the FINRA Name Change process is completed. There are plans to potentially pay dividends in the future once the company's situation allows.

Management Comments

• Management believes that the AI financial management software segment of operations will provide meaningful revenue.
• Management believes that the success or failure of each movie project can impact BOXO's ability to raise funds for the next project timely.
• Management seeks to minimize financial liability risk through close monitoring and relationship with clients.
• Management believes that the company's services sell for margins comparable with others in similar industries, and margins will reflect efficiency, desirability, and ability to scale operations.
• Management plans to discuss and approve dividends in the future once the company's situation allows, expressing delight to share success with shareholders.

Industry Context

Livento Group operates in two distinct sectors: AI-driven financial management software and movie/game development. The AI software market is highly competitive and fragmented, requiring continuous innovation to maintain a competitive edge. The movie production industry is capital-intensive, with project success heavily reliant on securing substantial funding and retaining key talent, often through personal relationships rather than formal agreements. The company's strategy involves leveraging its AI software for stable income while pursuing high-potential, albeit high-risk, entertainment projects.

Comparison to Industry Standards

• The filing states that the company's services sell for margins comparable with others in industries similar to theirs, but does not provide specific comparable companies, projects, or detailed industry benchmarks.
• The company's AI software, Elisee, is described as a unique platform, but no specific competitive analysis or market share data against industry leaders is provided.
• For movie projects, the filing notes that production costs frequently exceed $30 million, which is typical for feature film budgets, but does not compare BOXO's specific project returns or success rates against industry averages or specific studios.

Corporate Governance

Legal Proceedings

• The company currently has no active legal proceedings.

Related Party Transactions

• Historically, NuGene's sole customer in 2007 was GIAA, an affiliated entity owned by the founders.
• NuGene manufactured its products at a small laboratory facility leased from an affiliated entity owned by one of the founders.
• Revenues were generated from Advanced Surgical Partners (ASP), an affiliate also owned by the CEO and Chairman of the Board (Messrs. Ali and Mohammed Kharazmi), for providing Plasma Rich Platelet and Stem Cell injections.
• David Stybr, the CEO, holds all 100 shares of the super-voting preferred stock, giving him 51% of the shareholder voting power and control over the company.

Stakeholder Impact

• Shareholders: Experience dilution from common stock issuance, face high investment risk due to limited resources, ongoing losses, and concentrated control by the CEO. Potential for future dividends is mentioned but not assured.
• Employees/Consultants: The BOXO team relies on personal relationships rather than formal agreements, posing a risk of key consultants leaving, which could impact project continuity.
• Customers: Users of Elisee software and recipients of Global Dot Logistics services are expected to see continued service, with Elisee anticipating an upgraded version and increased client base.
• Creditors: The company has current liabilities and long-term liabilities, including a new financing agreement, and faces risks of cash flow problems if clients have financial difficulties.
• Suppliers: Relationships with suppliers are noted as important for procuring materials at better pricing, indicating their role in cost management.

Next Steps

• Complete the FINRA Name Change process to unlock new opportunities for Global Dot Logistics and BOXO movie projects.
• Continue development and upgrades for the Elisee AI machine learning program to achieve the expected $2.5 million annual revenue target from 2025.
• Further develop movie and game assets, aiming for completion within 15-18 months per project, and secure distribution deals.
• Management will discuss and potentially approve dividend payments in the future once the company's financial situation allows.

Key Dates

Recommendation

Despite a net profit in Q2 2025, the overall six-month performance shows a significant swing from profit to loss, coupled with a substantial decline in core revenues. The company operates with limited cash resources for its growth plans and relies heavily on speculative ventures like movie production, which are capital-intensive and inherently risky. The high accumulated deficit, concentrated ownership, and penny stock status further amplify investment risk, making it a highly speculative and unfavorable investment at this time.

Keywords

AI software, movie production, entertainment industry, financial management software, SEC filing, quarterly report, corporate finance, risk management, corporate governance, Livento Group, BOXO Productions, Elisee